 |
市場調查報告書
商品編碼
2048583
非類固醇消炎劑（NSAIDs）市場規模、佔有率和成長分析：按藥物類型、給藥途徑、應用、分銷管道、最終用戶、劑型和地區分類 - 產業預測，2026-2033年Non-steroidal Anti-inflammatory Drugs Market Size, Share, and Growth Analysis, By Drug Type (Ibuprofen, Naproxen), By Route of Administration, By Application, By Distribution Channel, By End User, By Dosage Form, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球非類固醇消炎劑(NSAID) 市場價值為 248 億美元，預計從 2025 年的 262.1 億美元成長到 2033 年的 408.4 億美元，預測期（2026-2033 年）的複合年成長率為 5.7%。
全球非類固醇消炎劑(NSAID) 市場成長的主要驅動力是人們對有效緩解疼痛和發炎的持續需求，而這種需求又受到人口老化以及骨關節炎和類風濕性關節炎等慢性疾病日益普遍的影響。該市場涵蓋非處方藥和處方藥，從傳統水楊酸鹽到現代 COX-2 抑制劑的演變提高了人們對藥物安全性的認知。推動市場成長的關鍵因素包括學名藥的增加和創新製劑的研發，這使得製造商能夠開發出差異化產品，例如外用凝膠和緩釋片。此外，人工智慧 (AI) 透過簡化標靶識別和改進臨床規劃，最佳化了 NSAID 的研發流程，從而消除了研發瓶頸並提高了生產效率。各公司正致力於在新興市場和慢性病護理領域開展夥伴關係，從而創造擴充性的成長機會。
全球非類固醇消炎劑（NSAID）市場促進因素
全球非類固醇消炎劑(NSAID) 市場的主要驅動力是患者對有效緩解疼痛方案的持續需求，這些方案適用於多種急慢性疾病。由於 NSAID 起效迅速且安全性良好，醫療專業人員通常更傾向於選擇 NSAID，這導致其處方率和患者接受度不斷提高。為此，製藥公司正致力於確保強大的生產能力和可靠的供應鏈，同時努力提高醫療專業人員對這些藥物的認知和理解。這些努力共同支撐了 NSAID 在門診和住院治療中的持續應用，鞏固了其在全球疼痛管理策略中的重要角色。
全球非類固醇消炎劑（NSAID）市場面臨的限制因素
非類固醇消炎劑)相關的胃腸道、心血管和腎臟副作用引發的持續安全擔憂，促使醫療專業人員在選擇治療方法時更加謹慎，尤其是在高風險患者群體中。這種對潛在風險日益增強的認知，導致了更嚴格的監管建議和更保守的治療指南，從而遏制了此類藥物的濫用。因此，人們開始轉向替代鎮痛藥和非藥物療法，阻礙了市場成長。此外，這種謹慎的做法也影響了產品定位，迫使製造商在進入市場時，優先考慮安全訊息的傳播和風險緩解措施，而不是激進的擴大策略。
全球非類固醇消炎劑（NSAIDs）市場趨勢
全球非類固醇消炎劑(NSAID) 市場正經歷著向整合式數位化醫療模式的重大轉變，這種模式旨在提高治療的可及性和個人化程度。數位平台與臨床工作流程的整合促進了遠端醫療諮詢和即時症狀追蹤，使醫療專業人員能夠有效地客製化 NSAID 治療方案。這一趨勢也受到以價值為導向的醫療模式的推動，該模式優先考慮患者的治療效果和體驗，加速了支持遠距患者管理的創新製劑的研發。製藥公司、醫療 IT 開發商和醫療服務提供者之間的合作正在建立一個生態系統，使 NSAID 能夠透過互聯的患者護理解決方案實現差異化，最終促進市場成長並增強競爭力。
目錄
介紹
- 調查目的
- 市場定義和範圍
調查方法
- 研究過程
- 二級資料和一級資料的方法
- 市場規模估算方法
執行摘要
- 全球市場展望
- 市場主要亮點
- 細分市場概覽
- 競爭環境概述
市場動態及展望
- 總體經濟指標
- 促進者和機會
- 抑制因素和挑戰
- 供給面趨勢
- 需求面趨勢
- 波特的分析和影響
關鍵市場分析
- 關鍵成功因素
- 影響市場的因素
- 主要投資機會
- 生態系測繪
- 2025年市場魅力指數
- PESTLE分析
- 監理情勢
- 價值鏈分析
- 案例研究
- 技術評估
- 客戶和採購標準分析
- 管道分析
- 疾病流行病學
全球非類固醇消炎劑(NSAIDs) 市場規模：依藥物類型分類
- Ibuprofen
- 萘普生
- 阿斯匹靈
- 雙氯芬酸鈉
- 塞來昔布
- Ketorolac
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：依給藥途徑分類
- 口服
- 局部的
- 注射
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：按應用領域分類
- 疼痛管理
- 關節炎治療
- 發熱管理
- 術後疼痛
- 肌肉骨骼疾病
- 其他
全球非類固醇消炎劑(NSAIDs) 市場規模：依分銷管道分類
- 醫院藥房
- 零售藥房
- 網路藥房
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：依最終用戶分類
- 醫院
- 診所
- 居家醫療
- 運動醫學中心
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：按劑型分類
- 片劑和膠囊
- 乳霜/凝膠
- 注射藥物
- 暫停
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：按地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
- 拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家
競爭資訊
- 前五大公司對比
- 主要公司2025年的市場定位
- 主要市場公司採取的策略
- 近期市場趨勢
- 企業市場占有率分析，2025 年
- 主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）
主要公司簡介
- Pfizer Inc.
- GlaxoSmithKline plc
- Bayer AG
- Sanofi SA
- Johnson & Johnson
- AbbVie Inc.
- Novartis AG
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Limited
- Dr. Reddy's Laboratories Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Aurobindo Pharma Limited
- Cipla Limited
- Hikma Pharmaceuticals PLC
- Alkem Laboratories Ltd.
- Zydus Lifesciences Limited
- Lupin Limited
- Torrent Pharmaceuticals Ltd.
- Endo International plc
結論與建議
目錄
介紹
- 調查目的
- 市場定義和範圍
調查方法
- 研究過程
- 二級資料和一級資料的方法
- 市場規模估算方法
執行摘要
- 全球市場展望
- 市場主要亮點
- 細分市場概覽
- 競爭環境概述
市場動態及展望
- 總體經濟指標
- 促進者和機會
- 抑制因素和挑戰
- 供給面趨勢
- 需求面趨勢
- 波特的分析和影響
關鍵市場分析
- 關鍵成功因素
- 影響市場的因素
- 主要投資機會
- 生態系測繪
- 2025年市場魅力指數
- PESTLE分析
- 監理情勢
- 價值鏈分析
- 案例研究
- 技術評估
- 客戶和採購標準分析
- 管道分析
- 疾病流行病學
全球非類固醇消炎劑(NSAIDs) 市場規模：依藥物類型分類
- Ibuprofen
- 萘普生
- 阿斯匹靈
- 雙氯芬酸鈉
- 塞來昔布
- Ketorolac
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：依給藥途徑分類
- 口服
- 局部的
- 注射
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：按應用領域分類
- 疼痛管理
- 關節炎治療
- 發熱管理
- 術後疼痛
- 肌肉骨骼疾病
- 其他
全球非類固醇消炎劑(NSAIDs) 市場規模：依分銷管道分類
- 醫院藥房
- 零售藥房
- 網路藥房
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：依最終用戶分類
- 醫院
- 診所
- 居家醫療環境
- 運動醫學中心
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：按劑型分類
- 片劑和膠囊
- 乳霜/凝膠
- 注射藥物
- 暫停
- 其他
全球非類固醇消炎劑（NSAIDs）市場規模：按地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
- 拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家
競爭資訊
- 前五大公司對比
- 主要公司2025年的市場定位
- 主要市場公司採取的策略
- 近期市場趨勢
- 企業市場占有率分析，2025 年
- 主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）
主要公司簡介
- Pfizer Inc.
- GlaxoSmithKline plc
- Bayer AG
- Sanofi SA
- Johnson & Johnson
- AbbVie Inc.
- Novartis AG
- Boehringer Ingelheim International GmbH
- Sun Pharmaceutical Industries Limited
- Dr. Reddy's Laboratories Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Aurobindo Pharma Limited
- Cipla Limited
- Hikma Pharmaceuticals PLC
- Alkem Laboratories Ltd.
- Zydus Lifesciences Limited
- Lupin Limited
- Torrent Pharmaceuticals Ltd.
- Endo International plc
結論與建議
Global Non-Steroidal Anti-Inflammatory Drugs Market size was valued at USD 24.8 Billion in 2024 and is poised to grow from USD 26.21 Billion in 2025 to USD 40.84 Billion by 2033, growing at a CAGR of 5.7% during the forecast period (2026-2033).
The global non-steroidal anti-inflammatory drugs (NSAIDs) market is significantly driven by the continuous demand for effective pain and inflammation relief, fueled by an aging population and a rise in chronic conditions like osteoarthritis and rheumatoid arthritis. This market includes a mix of over-the-counter analgesics and prescription drugs, with the evolution from historical salicylates to modern COX-2 innovations enhancing perceptions of safety. Key factors propelling growth include increased genericization and innovative formulations, enabling manufacturers to create differentiated products such as topical gels and extended-release tablets. Additionally, artificial intelligence is optimizing NSAID development by streamlining target identification and improving clinical planning, thus reducing development bottlenecks and enhancing manufacturing efficiency. Companies are focusing on emerging markets and chronic care partnerships, creating scalable growth opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Steroidal Anti-Inflammatory Drugs market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Non-Steroidal Anti-Inflammatory Drugs Market Segments Analysis
Global non-steroidal anti-inflammatory drugs market is segmented by drug type, route of administration, application, distribution channel, end user, dosage form and region. Based on drug type, the market is segmented into Ibuprofen, Naproxen, Aspirin, Diclofenac, Celecoxib, Ketorolac and Others. Based on route of administration, the market is segmented into Oral, Topical, Injectable and Others. Based on application, the market is segmented into Pain Management, Arthritis Treatment, Fever Management, Postoperative Pain, Musculoskeletal Disorders and Others. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on end user, the market is segmented into Hospitals, Clinics, Home Care Settings, Sports Medicine Centers and Others. Based on dosage form, the market is segmented into Tablets & Capsules, Creams & Gels, Injections, Suspensions and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Non-Steroidal Anti-Inflammatory Drugs Market
The Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is significantly driven by the persistent demand for effective pain relief solutions applicable to various acute and chronic conditions. Healthcare professionals often favor NSAIDs due to their rapid efficacy and well-documented safety profiles, which leads to increased prescription rates and patient acceptance. In response, pharmaceutical companies focus on ensuring strong production capabilities and reliable supply chains while enhancing awareness and familiarity among healthcare providers regarding these drugs. This combination supports the ongoing reliance on NSAIDs in both outpatient and inpatient settings, reinforcing their essential role in pain management strategies globally.
Restraints in the Global Non-Steroidal Anti-Inflammatory Drugs Market
Ongoing safety concerns regarding the gastrointestinal, cardiovascular, and renal side effects linked to the use of non-steroidal anti-inflammatory drugs prompt healthcare professionals to approach therapy selection with increased caution, particularly for at-risk populations. This heightened awareness of potential risks has led to stricter regulatory advisories and more conservative treatment guidelines that discourage the indiscriminate prescribing of these medications. Consequently, there is a shift towards alternative analgesics and non-pharmacological treatments, which restricts market growth. Additionally, this cautious approach impacts product positioning, compelling manufacturers to prioritize safety communication and risk mitigation strategies over aggressive expansion tactics in their market endeavors.
Market Trends of the Global Non-Steroidal Anti-Inflammatory Drugs Market
The Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is witnessing a significant shift towards integrated digital care models, enhancing treatment accessibility and personalization. The convergence of digital platforms with clinical workflows facilitates telemedicine consultations and real-time symptom tracking, enabling healthcare providers to customize NSAID therapies effectively. This trend is further propelled by a focus on value-based healthcare, which prioritizes patient outcomes and experience, encouraging innovative formulations that support remote patient management. Collaborative efforts among pharmaceutical companies, health IT developers, and healthcare providers are fostering an ecosystem that allows NSAIDs to be differentiated through connected patient care solutions, ultimately enhancing market growth and competitiveness.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Case Studies
- Technology Assessment
- Customer & buying Criteria Analysis
- Pipeline Analysis
- Disease Epidemiology
Global Non-steroidal Anti-inflammatory Drugs Market Size by Drug Type & CAGR (2026-2033)
- Market Overview
- Ibuprofen
- Naproxen
- Aspirin
- Diclofenac
- Celecoxib
- Ketorolac
- Others
Global Non-steroidal Anti-inflammatory Drugs Market Size by Route of Administration & CAGR (2026-2033)
- Market Overview
- Oral
- Topical
- Injectable
- Others
Global Non-steroidal Anti-inflammatory Drugs Market Size by Application & CAGR (2026-2033)
- Market Overview
- Pain Management
- Arthritis Treatment
- Fever Management
- Postoperative Pain
- Musculoskeletal Disorders
- Others
Global Non-steroidal Anti-inflammatory Drugs Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Global Non-steroidal Anti-inflammatory Drugs Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals
- Clinics
- Home Care Settings
- Sports Medicine Centers
- Others
Global Non-steroidal Anti-inflammatory Drugs Market Size by Dosage Form & CAGR (2026-2033)
- Market Overview
- Tablets & Capsules
- Creams & Gels
- Injections
- Suspensions
- Others
Global Non-steroidal Anti-inflammatory Drugs Market Size & CAGR (2026-2033)
- North America (Drug Type, Route of Administration, Application, Distribution Channel, End User, Dosage Form)
- US
- Canada
- Europe (Drug Type, Route of Administration, Application, Distribution Channel, End User, Dosage Form)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Drug Type, Route of Administration, Application, Distribution Channel, End User, Dosage Form)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Drug Type, Route of Administration, Application, Distribution Channel, End User, Dosage Form)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Drug Type, Route of Administration, Application, Distribution Channel, End User, Dosage Form)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boehringer Ingelheim International GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dr. Reddy's Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Viatris Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aurobindo Pharma Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cipla Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hikma Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alkem Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zydus Lifesciences Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lupin Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Torrent Pharmaceuticals Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Endo International plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
非類固醇消炎劑市場：2026-2032年全球市場預測（依藥物類別、劑型、給藥途徑、處方狀態、上市方式、病患群體、適應症、最終用戶和分銷管道分類）
Mometasone市場：依劑型、適應症、給藥途徑、通路及地區分類。抗發炎治療市場：2026-2032年全球市場預測（依治療分類、作用機制、給藥途徑、適應症、通路及最終用戶分類）
全球抗發炎治療藥物市場規模、佔有率、趨勢和成長分析報告（2026-2034年）
抗發炎治療市場分析及預測（至2035年）：類型、產品類型、服務、技術、應用、最終用戶、組件、部署模式、解決方案、開發階段
抗發炎藥物市場機會、成長要素、產業趨勢分析及2026年至2035年預測全球牙科抗發炎藥物市場（按藥物分類、給藥途徑、劑型、應用、最終用途和分銷管道分類）預測（2026-2032年）類固醇MRA市場按產品類型、適應症、給藥途徑、最終用戶和分銷管道分類－2026-2032年全球預測
抗發炎治療藥物市場規模、佔有率和成長分析（按藥物類別、適應症、用途、通路和地區分類）－2026-2033年產業預測
非類固醇抗發炎藥市場規模及預測（2021-2031年），全球及區域佔有率、趨勢和成長機會分析報告涵蓋：藥物類別、給藥途徑、適應症、配銷通路和地理